| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/30/1992 | EP0506463A2 New compounds, named the "leustroducsins" their preparation and their therapeutic uses |
| 09/30/1992 | EP0506325A1 Guluronic acid polymers and use of same for inhibition of cytokine production |
| 09/30/1992 | EP0505901A2 Use of 1-phenoxycarbonyl-2-pyrralidinone derivatives for treating or preventing platelet aggregation |
| 09/30/1992 | EP0505868A2 N-Acyl-alpha-aminoacids derivatives |
| 09/30/1992 | EP0505552A1 Megakaryocyte maturation factors |
| 09/30/1992 | EP0505385A1 Anti-aggregatory peptides containing a mercaptan or sulfide moiety |
| 09/29/1992 | WO1992017507A1 Anticoagulants and processes for preparing such |
| 09/29/1992 | WO1992017196A1 Anti-thrombotic peptides and pseudopeptides |
| 09/29/1992 | US5151431 4,5-dihydro-6H-imidazo[4,5,1-ij]quinolin-6-one-6-oxime-O-sulfonic acid derivatives useful for treating hypertension or edema |
| 09/29/1992 | US5151423 Antiinflammatory agents or antiallergens |
| 09/29/1992 | US5151360 Antitumor agents or anticarcinogenic agents |
| 09/29/1992 | US5151355 Process for the production of high purity thrombin |
| 09/29/1992 | US5151268 DNA cloning vectors for genetic engineering |
| 09/29/1992 | CA2107124A1 Anticoagulants and processes for preparing such |
| 09/29/1992 | CA2107088A1 Anti-thrombotic peptides and pseudopeptides |
| 09/28/1992 | CA2064126A1 Compounds, named the "leustroducins", their preparation and their therapeutic uses |
| 09/27/1992 | CA2061661A1 N-acyl-.alpha.-amino derivatives |
| 09/26/1992 | CA2063773A1 Anti-platelet aggregating agent |
| 09/23/1992 | EP0504241A1 Proteins and nucleic acids |
| 09/23/1992 | EP0504177A1 A mammalian cytokine, il-11 |
| 09/22/1992 | US5149879 Polysulfides compounds and lipid peroxidation inhibitor containing the polysulfide compounds as active ingredient |
| 09/22/1992 | US5149540 Hemostatic agents |
| 09/19/1992 | WO1992016197A1 Composition and method containing optically pure (s) metoprolol |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/19/1992 | CA2106494A1 Composition and method containing optically pure (s) metoprolol |
| 09/17/1992 | WO1992015686A1 Modified factor vii |
| 09/17/1992 | WO1992015609A1 Compositions and methods to inhibit the activation of active factor xiii |
| 09/17/1992 | WO1992015607A2 Phenyl amidines derivatives useful as platelet aggregation inhibitors |
| 09/17/1992 | WO1992015324A1 Preparation of factor ix |
| 09/17/1992 | WO1992015294A1 Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
| 09/17/1992 | CA2105863A1 Compositions and methods to inhibit the activation of active factor xiii |
| 09/17/1992 | CA2104951A1 Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
| 09/16/1992 | EP0504064A1 Novel thrombin inhibitors |
| 09/16/1992 | EP0503991A1 Process for preparing a highly purified standardized concentrate of human von Willebrand factor on industrial scale, appropriate for therapeutic use |
| 09/16/1992 | EP0503548A1 Cyclic urea derivatives, medicaments contaning them and process for their preparation |
| 09/16/1992 | EP0503203A1 Novel thrombin inhibitors |
| 09/16/1992 | EP0503050A1 Hybrid growth factors |
| 09/16/1992 | EP0502962A1 Hirudine polyalkylene glycol conjugates. |
| 09/16/1992 | EP0502892A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 09/15/1992 | US5147885 Glaucoma, anticoagulants |
| 09/15/1992 | US5147883 Acylbenzoxazolinones compounds |
| 09/15/1992 | US5147799 Repopulation of macrophages and granulocytes using transforming growth factor-beta |
| 09/15/1992 | US5147790 Tissue plasminogen activator, biosynthesis |
| 09/15/1992 | US5147638 Tumor necrosis factor, antibodies, cytokines |
| 09/15/1992 | CA1307525C Sulfoamino derivatives of chondroitin sulfates, of dermatan sulfate and hyaluronic acid and their pharmacological properties |
| 09/13/1992 | CA2062655A1 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/12/1992 | WO1992016612A2 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 09/12/1992 | CA2105997A1 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 09/09/1992 | EP0502550A1 Colominic acid and partial hydrolysis products of colominic acid for the preparation of medicaments for the treatment of hepatitis, nephritis and arthritis |
| 09/09/1992 | EP0502536A1 Phenyl amidines derivatives useful as platelet aggregation inhibitors |
| 09/09/1992 | EP0502498A1 Phenoxyalkanoic acid derivatives and process for preparation thereof |
| 09/09/1992 | EP0502171A1 Composition for inducing granulocyte production or b cell production in peripheral blood |
| 09/09/1992 | EP0502124A1 Peptides and antibodies that inhibit integrin-ligand binding |
| 09/09/1992 | EP0502117A1 Polymers with alkyl- or heteroalkyl-aryl backbone and pharmaceutical compositions incorporating same |
| 09/09/1992 | EP0316322B1 Tetrapeptide inhibiting the proliferation cycle of haematopoietic strain cells, methods of production and applications thereof |
| 09/09/1992 | EP0292517B1 Improvements in or relating to the use of epidermal growth factor |
| 09/08/1992 | US5145868 Alkanophenones useful for treating allergies |
| 09/08/1992 | US5145867 Sickle-cell anemia |
| 09/08/1992 | CA2062370A1 Pharmaceutical preparation |
| 09/08/1992 | CA1307373C Process for the isolation and preparation of a pasteurized alpha_-antiplasmin product |
| 09/08/1992 | CA1307277C Process for the preparation of a stable modification of torasemide and pharmaceutical compositions containing it |
| 09/03/1992 | WO1992014750A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/03/1992 | CA2104394A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/02/1992 | EP0501821A2 Anti-thrombin polypeptides |
| 09/02/1992 | EP0501280A2 Renin-inhibiting peptide analogues |
| 09/02/1992 | EP0500893A1 Preservation of blood, tissues and biological fluids |
| 09/02/1992 | EP0500734A1 Protein complexes having factor viii:c activity and production thereof |
| 09/02/1992 | EP0500621A1 Cycloalkyl-substituted glutaramide diuretic agents |
| 09/02/1992 | CA2062065A1 Peptide analogues |
| 09/01/1992 | US5144035 Chemical intermediates for platelet activating factor antagonists |
| 09/01/1992 | US5143901 Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same |
| 09/01/1992 | US5143829 One of the alanine residues following N-terminal methionine is removed |
| 08/29/1992 | CA2061920A1 Anti-thrombin polypeptides |
| 08/27/1992 | DE4105570A1 Verwendung eines bakterien- und eiweissfreien filtrats Use of a protein-free filtrate of bacteria and |
| 08/26/1992 | EP0499987A1 Platelet activating factor antagonists |
| 08/26/1992 | EP0499926A1 2-Substituted quinolines, process for their preparation as well as their use in medicaments |
| 08/26/1992 | EP0499831A2 Combination of active agents comprising a sydnonimin derivate and a hirudin |
| 08/26/1992 | EP0480925A4 Fluorocarbon emulsions having saturated phospholipid emulsifiers |
| 08/26/1992 | EP0246322B1 Treatment of aids-type disease |
| 08/26/1992 | CN1017992B Process for preparing piperidine opioid antagonists |
| 08/25/1992 | US5141958 Inhibition of cell adhesion for reducing cancer cell metastases |
| 08/25/1992 | US5141957 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c |
| 08/25/1992 | US5141947 Fibrinolysis-enhancing agents |
| 08/25/1992 | CA1306677C Composition for transdermal therapeutic systems of loop diuretics and a process for its preparation |
| 08/23/1992 | WO1992014478A1 Process for producing a medical composition with a bone marrow protective effect and an anti-neoplastic effect |
| 08/23/1992 | CA2101645A1 Process for the production of a pharmaceutical preparation for producing a protective effect on bone marrow and an antineoplastic effect |
| 08/21/1992 | WO1992014732A1 Indoles useful as platelet activating factor antagonists |
| 08/21/1992 | CA2100682A1 Indoles useful as platelet activating factor antagonists |
| 08/21/1992 | CA2061488A1 Combination of active substances comprising a sydnone imine and a hirudin |
| 08/20/1992 | WO1992014150A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | WO1992013952A1 Improved inhibitors of thrombin |
| 08/20/1992 | WO1992013879A1 Novel peptides with anticoagulatory effect |
| 08/20/1992 | WO1992013875A1 Improved blood substitute |
| 08/20/1992 | WO1992013561A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 08/20/1992 | WO1992013552A1 Anti-aggregatory peptides containing an aromatic ester or amide |
| 08/20/1992 | WO1992013522A1 Orthomolecular method of treating sickle cell disease |
| 08/20/1992 | CA2103893A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/19/1992 | EP0499444A1 N-imidazolyl derivatives of substituted alkoxyimino tetrahydronaphthalenes and chromans |
| 08/19/1992 | EP0499142A2 Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs |
| 08/19/1992 | CN1063685A Calcium uptake inhibitors |